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meetings to review circumstances surrounding falls.
Medications review to determine those that most greatly
increase risk of falls. Patients not assessed as high fall risk
were placed on bed alarms for two hours after receiving
these meds.
All staff members received education on Crucial Conver-
sations and how to address patients’ refusal of bed alarm
usage.
Continued refusal of the bed alarm was escalated to
nursing leadership.
Collaboration with Physical Therapyethe use of a
communication board to report activity and required assis-
tance by staff.
Findings & Interpretation: 2012 total falls were 19, fall rate
3.02/ 1000 patient days.
2013 total falls were 27, fall rate 4.45/ 1000 patient days.
2014 falls through 3rd quarter is 10, fall rate 2.08/ 1000
patient days.
Discussion & Implications: Consistent implementation of
any strategy is the best way to ensure sustained results.
Nurse leader rounding to validate use of the bed alarm and
consistent messaging to staff and patients is necessary to
keep protocols high priority.
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Autologous stem cell transplant (ASCT) and various novel
drug combination strategies are designed to improve
outcome. Relapse within 12 months of stem cell transplant
predicts poor outcome for patients with (MM). Historically,
extramedullary plasmacytomas are not included in staging or
as a prognostic feature for patients undergoing transplants for
multiple myeloma.
Methods, Intervention, & Analysis: We evaluated charac-
teristics of plasmacytomas (PCM) in patients undergoing
ASCT transplant for diagnosis of MM. We retrospectively
analyzed 251 consecutive (M137:F107) ASCTs for MM be-
tween December 2011 and June 2014, after new triple com-
bination agents were introduced in the therapy of (MM).
Median agewas 57 years (38-76) and length of follow-upwas
538 days (120 - 1042 days). Bone marrow cytogenetics was
available in 230 (94.3%) patients. Various pretransplantcharacteristics including age, cytogenetics, and plasma cell
percentage were evaluated for impact on overall survival and
disease progression.
A total of 159 (65%) patients had either extraosseous or
extramedullary plasmacytomas at presentation and 85 (35%)
patients had no lytic lesions or any plamacytomas. 52 (21.3%)
patients had extramedullary PCM without any lytic lesions.
Plasma cells > 20% was seen in 38.2% (n¼20) in PCM
compared to 62% (n¼152) in whole group. Prior MGUS
(n¼26) or smoldering myeloma (n¼7) was seen in 14% (33/
244) patients but only 7.6% (4/52) in PCM group. Prior soli-
tary Plasmacytomas were seen in 21%( 11/52) PCM patients.
Trisomy 11 or t (11:14) was seen in 3% (n¼8) in PCM
compared to 12% (n¼6) in all pts. Hyperdiploidy was seen in
4% (2/52) compared to 9% (22/244) patients.
Findings & Interpretation: The median survival was 623
days (20 days -1897 days) for PCM patients compared to 522
days (89 days -1897 days) for all patients. PCM pts developed
recurrent PCM after autologous transplant in 33% (17/52)
cases. One third of patients with recurrent PCM (6/17) died of
(PCM) progression.
Discussion & Implications: In conclusion, patients pre-
senting as PCM have more aggressive clinical presentation.
Pre and post transplant strategies need to be better deﬁned
to improve outcome of patients with PCM recurrences post
transplant.586
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Prolonged neutropenia and mucosal barrier breakdown are
major treatment related toxicities contributing to central line
associated blood stream infections (CLABSIs) in bone marrow
transplant recipients. CLABSIs are preventable, costly, and
potentially deadly. Bone Marrow Transplant nurses have the
ability to reduce the number of CLABSIs through a variety of
techniques and practices.
Methods, Intervention, & Analysis: An evaluation of cur-
rent practice and areas for improvement were identiﬁed
which led to the development of a comprehensive unit based
safety program (CUSP) team. A “Back to Basics Campaign”
was initiated by the team that included proper hand hygiene,
aseptic techniques when accessing central lines, environ-
mental practices, and blood culture procedure techniques.
Additionally, there were speciﬁc nurse and patient educa-
tion, environmental practices (i.e., high-touch surface infec-
tion control, decreasing clutter in recipient rooms, ultra
violet light decontamination cleaning, isolation practice
changes), and CLABSI drill downs by the clinical nurse leader
and team. CLABSI rates were measured before and after
implementation of education and clinical practice changes.
The overall goals were to improve patient outcomes and
reduce CLABSI rates below national benchmark. Compliance
audits were performed weekly by nursing leadership to
validate nurse and patient practices.
Findings & Interpretation: CLABSI rates prior to imple-
mentation were 9.938 and three months after the in-
terventions were 2.42. Mucosal barrier infections were
unpreventable and included in the data.
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hospital efforts and evidence-based practices to improve
quality of care for optimal patient outcomes. Nursing lead-
ership is instrumental in providing structure, consistency,
and speciﬁc feedback on progress as well as real time CLABSI
rates to the team. CLABSIs are common and can be fatal in the
transplant population. Continued surveillance of techniques
and practices learned are ongoing and monitored for
compliance. Improvements in all aspects of nursing carewith
meticulous infection control techniques and environmental
monitoring is essential for improved patient outcomes and
reducing CLABSI rates in a bone marrow transplant pop-
ulation.587
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Maintaining a standardized process for psychosocial distress
screening (PDS) for cancer patients is a 2015 standard for
Commission on Cancer accredited hospitals. While many pa-
tients undergoing hematopoietic cell transplantation (HCT)
have a cancer diagnosis, there are distinctions between the
HCT process and oncology care, including the signiﬁcant role
of the HCTcaregiver and the treatment of non-cancer diseases.
These variations require modiﬁcation of PDS processes to ﬁt
the HCT setting. The objective was to develop and implement
a phone-based PDS process for patients and caregivers pre-
HCT.
Methods, Intervention, & Analysis: An evidence based
approach was used to apply an oncology-based PDS standard
to HCT. This approach included: 1) review literature on PDS
practices for HCT; 2) select and modify a screening tool; 3)
develop a pilot program and evaluation plan; and 4) use
preliminary results to guide program changes.
Findings & Interpretation: The literature review resulted in
359 abstracts (PubMed, 2009 e 2014); 41 relevant articles
were synthesized. From among 16 screening tools, the
Distress Thermometer was selected with associated problem
lists and referral plans tailored to HCT. An implementation
plan for the phone-based PDS pilot was developed. Program
objectives were to: 1) design a standard process for PDS in
HCT; 2) determine average PD score of pilot participants; and
3) provide participants with appropriate resources and/or
referrals to address psychosocial needs. Preliminary results
will be presented including: 1) baseline data for developing
goals around number of PDS completed and referrals made;
2) mean PD score of pilot participants, 3) perceived help-
fulness of PDS (staff); and 4) overall satisfaction with pro-
gram (staff).
Discussion & Implications: These results will inform the
comprehensive formative evaluation plan. Lessons learned
from this evidence-based pilot programwill provide relevant
insight to nurses and social workers adapting this standard
to their practice. 1. American College of Surgeons Commis-
sion on Cancer. Cancer Program Standards 2012, Version 1.1:
Ensuring Patient-Centered Care. Available at: http://
www.facs.org/cancer/coc/programstandards2012.html.
Accessed February 20, 2014. 2. Ransom, S., Jacobsen, P. B., &
Booth-Jones, M. (2006). Validation of the DistressThermometer with bone marrow transplant patients. Psy-
cho-Oncology, 15(7), 604e612.588
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Many transplant programs utilize the role of transplant case
manager/coordinator/navigator (CM) to coordinate care and
services for patients undergoing a blood or marrow trans-
plant. There is minimal literature available to describe the
signiﬁcance of the CM role for Blood and Marrow Transplant
(BMT) patients. The purpose of this study was to examine the
patient’s perception of both importance and performance of
selected core competencies by the BMT CM.
Methods, Intervention, & Analysis: Adult patients who had
received a transplant were surveyed to determine the
importance and performance of ﬁve selected core compe-
tencies (Oncology Nursing Society Oncology Nurse Navigator
Core Competencies, 2013). The anonymous survey used a ﬁve
item Likert scale to assess importance and performance of
the core competencies. Demographic questions included:
cancer diagnosis, type of transplant, sex, time since trans-
plant, and distance traveled to transplant center. Over a
period of 5 weeks, the survey was distributed to patients at
check-in for a post-transplant clinic appointment. Eighty
surveys were distributed with a 75% return rate. 56 surveys
were used for analysis of importance and performance of
core competencies.
Findings & Interpretation: Overall, the results were
exceedingly positive. The majority of patients perceived the
importance of the ﬁve competencies as “very important.”
Patients also indicated that they “strongly agreed” that CMs
are consistently performing the ﬁve core competencies. No
signiﬁcant differences were found when comparing sex, type
of transplant, distance travelled, time since transplant or
diagnosis. Numerous positive comments were included by
the patients. The high return rate may be interpreted that
patients value the role and feel a vested interest in sharing
their view regarding the role. Limitations to this study include
the small sample size and only one institution is represented.
Discussion & Implications: The role of case manager/coor-
dinator/navigator has been associated with positive out-
comes, including increased satisfaction, increased cost
effectiveness of care, and improved adherence to treatment
regimens. The transplant case manager plays a signiﬁcant
role in the care of the BMT patient. This study suggests that
patients ﬁnd the role of case manager extremely valuable.589
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